SmartPeople: Richard Davies
Richard Davies, vice president and solutions expert at CluePoints, says there’s “a huge opportunity” for operational efficiency gains in clinical trials
PharmaTimes Magazine Archive
Magazine highlights
View more from the latest edition
SmartPeople: Lotte Bjerre Knudsen
PharmaTimes talks to Lotte Bjerre Knudsen, inventor of diabetesdrug liraglutide and scientific vice president at Novo Nordisk
A need to know basis
Ten months since sweeping data privacy laws came into force in Europe, pharma companies are wrestling with the new ‘right to be forgotten’
The rise of the CRO
Dr Chris Doherty discusses the rise of clinical research organisations (CROs) from his vantage point as managing director at Alderley Park
Resistance is futile
An exciting, futuristic chapter for clinical trials has opened in which participant engagementwill flourish, expansive data will navigate the maze of disease and digital technology will take pharma and patients to previously unexplored dimensions. John Pinching reports.
Closing the gap
How seven innovations are accelerating research and bringing new data-driven insights to the clinical trial landscape, potentially reducing the time and cost of drug development
Introducing the Pharma Fast 50
PharmaTimes presents Alantra’s annual look at the fastest-growing pharma companies
What does the next decade hold for the NHS?
Steve How and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore some of the key aspirations of the NHS’ Long Term Plan
